# Angelini Lumira Biosciences Fund

> Angelini Lumira Biosciences Fund is a VC fund backing Medical, Health Care and Neuroscience. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Feb 2023
- Lead investor: 100%
- Last updated: Aug 2026

Angelini Lumira Biosciences Fund is a corporate venture capital fund established by Angelini Pharma.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |
| Neuroscience | 1 | 33% |
| Therapeutics | 1 | 33% |
| Biotechnology | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Series B | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cadence Neuroscience | Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with the procedurethat can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols.Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington. | $26M | Series B | Feb 28, 2023 |  |
| Damona Pharmaceuticals | Damona Pharmaceuticals is a pre-clinical pharmaceutical company treats and prevents cognitive deficits in a variety of brain disorders and during aging. | $5.5M | Seed | Sep 26, 2022 |  |
| GenEp | GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets. GenEp creates therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies. | $1.5M | Seed | Oct 26, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Jazz Venture Partners](https://shizune.co/investors/profile/jazz-venture-partners) — VC Fund, 2 deals together
- [Angelini Ventures](https://shizune.co/investors/profile/angelini-ventures) — VC Fund, 1 deal together
- CAMH — VC Fund, 1 deal together
- [F-Prime](https://shizune.co/investors/profile/f-prime-capital-partners) — VC Fund, 1 deal together
- [3B Future Health Fund](https://shizune.co/investors/profile/helsinn-investment-fund) — VC Fund, 1 deal together
- Kids Connect Charitable Fund — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Angelini Lumira Biosciences Fund invest in?

Angelini Lumira Biosciences Fund invests primarily in Medical, Health Care and Neuroscience startups, most often at Seed and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Angelini Lumira Biosciences Fund last invest?

The most recent investment recorded for Angelini Lumira Biosciences Fund closed in Feb 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co